Also of note, the developmental transcription factor SOX4, upregulated in DU145, has been shown to possess oncogenic activity in prostate cancer [72, 73], wheres Nestin has been associated with the drug resistant prostate stem population [74]. Here, NES is linked to prostate carcinoma.